Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)
Reducing and combatting the formation of dysfunctional proteins and promoting the formation of healthy proteins [11]
Its design supports multiple withdrawals from each vial, providing flexibility and efficiency for subcutaneous or intramuscular administration
Excessive IGF-1 signalling increases the activity of the insulin/IGF-1 pathway, which may accelerate some aspects of aging by leading to immunosuppression, cellular senescence, and chronic low-grade inflammation 51
By combining formulation expertise, flexible manufacturing, and market-driven product strategy, I help brands turn the potential of GHK-Cu peptides into products that genuinely strengthen their position in the skincare market